HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ali Afshar-Oromieh Selected Research

Prostatectomy (Retropubic Prostatectomy)

1/2021Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy-a multi-centre evaluation of 2533 patients.
12/201968Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study.
11/2017Intraindividual Comparison of 18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study.
5/2017Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ali Afshar-Oromieh Research Topics

Disease

61Prostatic Neoplasms (Prostate Cancer)
10/2022 - 10/2013
17Neoplasms (Cancer)
01/2022 - 03/2014
13Neoplasm Metastasis (Metastasis)
01/2022 - 08/2014
3Glioma (Gliomas)
10/2018 - 03/2014
2Lymphatic Metastasis
04/2020 - 01/2020
2Meningioma (Meningiomas)
02/2015 - 09/2012
1Fibrosis (Cirrhosis)
01/2022
1Epidermal Cyst (Sebaceous Cyst)
12/2021
1Hypoxia (Hypoxemia)
07/2021
1Lung Diseases (Lung Disease)
01/2021
1COVID-19
01/2021
1Malignant Pleural Effusion
10/2019
1Pain (Aches)
10/2018
1Xerostomia
06/2017
1Carcinoma (Carcinomatosis)
01/2016
1Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2014
1Astrocytoma (Pilocytic Astrocytoma)
03/2014
1Brain Neoplasms (Brain Tumor)
03/2014
1Glioblastoma (Glioblastoma Multiforme)
03/2014

Drug/Important Bio-Agent (IBA)

24LigandsIBA
12/2021 - 09/2012
24AntigensIBA
11/2021 - 11/2013
21gallium 68 PSMA-11IBA
01/2021 - 10/2013
8N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
08/2017 - 06/2014
5Radioisotopes (Radionuclides)IBA
01/2020 - 08/2016
4RadiopharmaceuticalsIBA
01/2022 - 06/2014
4PSMA-617IBA
01/2018 - 06/2015
3AndrogensIBA
01/2022 - 01/2017
3Edotreotide (SMT 487)IBA
02/2015 - 09/2012
2Biological ProductsIBA
10/2021 - 01/2018
2Choline (Choline Chloride)IBA
02/2020 - 01/2014
2IonsIBA
10/2018 - 01/2018
2CarbonIBA
10/2018 - 01/2018
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
08/2016 - 06/2015
2Urea (Carbamide)FDA LinkGeneric
01/2016 - 01/2016
1Adenosine Monophosphate (AMP)IBA
10/2022
1Erbium-169IBA
01/2022
1ChemokinesIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Proteins (Proteins, Gene)FDA Link
10/2021
1A-factor (Streptomyces)IBA
07/2021
1DiureticsIBA
01/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1Bombesin Receptors (Bombesin Receptor)IBA
11/2020
1Fluorine-18IBA
07/2020
1Furosemide (Lasix)FDA LinkGeneric
01/2020
1N 30IBA
01/2020
1Prostate-Specific Antigen (Semenogelase)IBA
12/2019
1FluoridesIBA
10/2018
1Technetium Tc 99m MedronateIBA
01/2018
1Androgen Receptors (Androgen Receptor)IBA
01/2017
1PSMA-11IBA
01/2016
1Tumor Biomarkers (Tumor Markers)IBA
01/2016
1Hormones (Hormone)IBA
01/2016
1Chelating AgentsIBA
01/2016
1LutetiumIBA
05/2015
1Peptide Receptors (Peptide Receptor)IBA
08/2014
1Dihydroxyphenylalanine (Dopa)IBA
03/2014
1fluorodopa F 18IBA
03/2014
1GalliumIBA
11/2013
1Somatostatin Receptors (Somatostatin Receptor)IBA
09/2012

Therapy/Procedure

23Therapeutics
10/2022 - 07/2014
11Castration
10/2022 - 07/2014
7Precision Medicine
12/2021 - 06/2015
7Radiotherapy
04/2020 - 09/2012
4Prostatectomy (Retropubic Prostatectomy)
01/2021 - 05/2017
2Lymph Node Excision (Lymph Node Dissection)
04/2020 - 01/2020
1Pleurodesis
10/2019
1Re-Irradiation
10/2018
1Heavy Ion Radiotherapy
01/2018
1Aftercare (After-Treatment)
01/2017